mycophenolate

mycophenolate

 [mi″ko-fen´o-lāt]
an immunosuppressant used as mycophenolate mofetil to prevent rejection of allogeneic cardiac, hepatic, and renal transplants; administered orally or intravenously.

mycophenolate

/my·co·pheno·late/ (-fen´o-lāt) an immunosuppressant used as m. mofetil to prevent rejection of allogeneic cardiac, hepatic, and renal transplants.

mycophenolate

(mī-kō-fē′nō-lāt)
An immunosuppressive drug used to prevent organ rejection after transplantation.
References in periodicals archive ?
7mg voclosporin BID and mycophenolate mofetil (MMF) or MMF and placebo, with both groups receiving a stringent oral corticosteroid taper.
Mycophenolate acid (MFA) is available in 2 forms: mycophenolate mofetil (MMF; CellCept, Roche, Nutley, New Jersey) and mycophenolate sodium (Myfortic, Novartis, East Hanover, New Jersey).
Refractory patients received a wide range of systemic agents--most commonly chloroquine (Aralen) and mycophenolate mofetil (Cellcept), followed by quinacrine, dapsone, methotrexate, belimumab (Benlysta), azathioprine, thalidomide (Thalomid), lenalidomide (Revlimid), prednisone, and rituximab (Rituxan), Ms.
Salinas needs P54,990 for his medicines: Tacrolimus six times a day at P1,320; Mycophenolate mofetil, four times a day at P508, and Amlodipine once a day at P5.
Mycophenolate mofetil (MMF), an immunosuppressive agent currently used in transplantology, can also be used as one of the therapeutic options in steroid dependent (SD), steroid resistant (SR), and frequently relapsing (FR) nephrotic syndrome in children [1-4].
Northbrook, IL, announced this week that ASTAGRAF XL for the prophylaxis of organ rejection in patients receiving a kidney transplant used with mycophenolate mofetil (MMF) and corticosteroids, with or without basiliximab induction, is now available in US pharmacies nationwide.
Ophthalmologists and eye specialists from the US and Europe focus on recent innovative treatment options, but begin with an outline of treatment principles and the most conventional treatments, including corticosteroids and other immunosuppresant agents, then discuss the newer available agents for intraocular inflammation, such as drugs adopted from rheumatology, mycophenolate mofetil, anti-tumor necrosis factor-alpha agents, anti-interleuken therapy, interferon-alpha therapy, rituximab, intravitreal injection therapy, corticosteroid intravitreal implants, and calcineurin inhibitor voclosporin, mammalian target of rapamycin inhibitor sirolumus, and the IL-1 trap rilonacept.
For patients with more severe disease or in any patients when steroids could not be reduced to acceptable levels, immunosuppressive agents such as azathioprine, mycophenolate mofetil, and methotrexate were recommended.
The animals receiving combined immunosuppression of both FK506 and mycophenolate likely benefited from the longer half-life of mycophenolate radicr than from its action.
Two drugs, tacrolimus (FK506) and mycophenolate, were used alone and in combination.
CHICAGO -- Newly updated American College of Rheumatology guidelines for the screening and management of lupus nephritis in adults, which are expected to be published in early 2012, focus largely on induction therapy with mycophenolate mofetil or cyclophosphamide and on maintenance therapy with mycophenolate mofetil and azathioprine.
Both Myfortic, known generically as mycophenolic acid, and CellCept, mycophenolate mofetil, are used to suppress the immune system to prevent patients' bodies from rejecting a transplanted organ.